The effects of low glycemic index diet on epileptic seizure frequency, oxidative stress, mental health, and health-related quality of life in children with drug-resistant epilepsy

IF 2.7 3区 医学 Q2 CLINICAL NEUROLOGY
Gamze Yurtdaş Depboylu , Olgay Bildik , Gülşah Kaner , Pınar Gençpınar , Nihal Olgaç Dündar
{"title":"The effects of low glycemic index diet on epileptic seizure frequency, oxidative stress, mental health, and health-related quality of life in children with drug-resistant epilepsy","authors":"Gamze Yurtdaş Depboylu ,&nbsp;Olgay Bildik ,&nbsp;Gülşah Kaner ,&nbsp;Pınar Gençpınar ,&nbsp;Nihal Olgaç Dündar","doi":"10.1016/j.seizure.2025.03.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>There is a gap in the existing literature regarding the evaluation of the effects of low glycemic index diet (LGID) on Turkish patients with drug-resistant epilepsy (DRE), as well as the impact of an LGID on oxidative stress markers in this population. This study aimed to evaluate the efficacy of an LGID on seizure frequency, oxidative stress markers [malondialdehyde (MDA), paraoxonase-1 (PON-1), total antioxidant status (TAS), and total oxidant status (TOS)], mental health, and health-related quality of life (HRQOL) in Turkish children with DRE.</div></div><div><h3>Methods</h3><div>The study used a pre-post design without a control group and involved 34 children with DRE. Seizure frequency, dietary intake, anthropometry, and biochemical parameters were assessed at baseline and after 3 months of LGID treatment. Behavioral and emotional difficulties were assessed with the “Strengths and Difficulties Questionnaire (SDQ)”. The depressive symptoms were evaluated using the “Children's Depression Inventory (CDI)” and HRQOL was assessed with the “Pediatric Inventory of Quality of Life (PedsQL)”.</div></div><div><h3>Results</h3><div>Thirty of the 34 included children completed the three-month LGID treatment. By the study's end, 38.2 % (13/34) achieved &gt;50 % seizure reduction and 41.2 % (14/34) were seizure-free. Glucose (<em>p</em> &lt; 0.001), insulin (<em>p</em> = 0.005), CRP (<em>p</em> = 0.046), and triglyceride levels (<em>p</em> = 0.015) significantly decreased. MDA levels decreased (<em>p</em> &lt; 0.001), whereas PON-1 levels increased significantly (<em>p</em> = 0.035). There was a significant improvement in all subscales of the HRQOL (<em>p</em> &lt; 0.001), as well as the total HRQOL and CDI scores (<em>p</em> &lt; 0.001). According to the SDQ, the conduct problems, hyperactivity/inattention, and emotional symptoms scores were significantly decreased. There was a negative correlation between MDA (<em>r</em> = -0.512, <em>p</em> = 0.005) and LGID efficacy after 3 months of LGID. Serum levels of MDA and glucose were positively correlated (<em>r</em> = 0.412, <em>p</em> = 0.033).</div></div><div><h3>Conclusion</h3><div>LGID shows promise in reducing seizures and improving oxidative stress, mental health, and quality of life for pediatric DRE in the short term. Further research is needed to address the limitations (small sample size, no control group, etc.) and investigate LGID's long-term effects.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"127 ","pages":"Pages 57-65"},"PeriodicalIF":2.7000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seizure-European Journal of Epilepsy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1059131125000755","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim

There is a gap in the existing literature regarding the evaluation of the effects of low glycemic index diet (LGID) on Turkish patients with drug-resistant epilepsy (DRE), as well as the impact of an LGID on oxidative stress markers in this population. This study aimed to evaluate the efficacy of an LGID on seizure frequency, oxidative stress markers [malondialdehyde (MDA), paraoxonase-1 (PON-1), total antioxidant status (TAS), and total oxidant status (TOS)], mental health, and health-related quality of life (HRQOL) in Turkish children with DRE.

Methods

The study used a pre-post design without a control group and involved 34 children with DRE. Seizure frequency, dietary intake, anthropometry, and biochemical parameters were assessed at baseline and after 3 months of LGID treatment. Behavioral and emotional difficulties were assessed with the “Strengths and Difficulties Questionnaire (SDQ)”. The depressive symptoms were evaluated using the “Children's Depression Inventory (CDI)” and HRQOL was assessed with the “Pediatric Inventory of Quality of Life (PedsQL)”.

Results

Thirty of the 34 included children completed the three-month LGID treatment. By the study's end, 38.2 % (13/34) achieved >50 % seizure reduction and 41.2 % (14/34) were seizure-free. Glucose (p < 0.001), insulin (p = 0.005), CRP (p = 0.046), and triglyceride levels (p = 0.015) significantly decreased. MDA levels decreased (p < 0.001), whereas PON-1 levels increased significantly (p = 0.035). There was a significant improvement in all subscales of the HRQOL (p < 0.001), as well as the total HRQOL and CDI scores (p < 0.001). According to the SDQ, the conduct problems, hyperactivity/inattention, and emotional symptoms scores were significantly decreased. There was a negative correlation between MDA (r = -0.512, p = 0.005) and LGID efficacy after 3 months of LGID. Serum levels of MDA and glucose were positively correlated (r = 0.412, p = 0.033).

Conclusion

LGID shows promise in reducing seizures and improving oxidative stress, mental health, and quality of life for pediatric DRE in the short term. Further research is needed to address the limitations (small sample size, no control group, etc.) and investigate LGID's long-term effects.
求助全文
约1分钟内获得全文 求助全文
来源期刊
Seizure-European Journal of Epilepsy
Seizure-European Journal of Epilepsy 医学-临床神经学
CiteScore
5.60
自引率
6.70%
发文量
231
审稿时长
34 days
期刊介绍: Seizure - European Journal of Epilepsy is an international journal owned by Epilepsy Action (the largest member led epilepsy organisation in the UK). It provides a forum for papers on all topics related to epilepsy and seizure disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信